These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17084395)

  • 1. Measuring estradiol levels after human chorionic gonadotropin administration for in vitro fertilization is not clinically useful.
    Chiasson MD; Bates GW; Robinson RD; Arthur NJ; Propst AM
    Fertil Steril; 2007 Feb; 87(2):448-50. PubMed ID: 17084395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer.
    Mitwally MF; Bhakoo HS; Crickard K; Sullivan MW; Batt RE; Yeh J
    Fertil Steril; 2006 Sep; 86(3):588-96. PubMed ID: 16814289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum estradiol levels are not detrimental to in vitro fertilization outcome.
    Wu CH; Kuo TC; Wu HH; Yeh GP; Tsai HD
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):54-9. PubMed ID: 17389191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy.
    Elgindy EA
    Fertil Steril; 2011 Apr; 95(5):1639-44. PubMed ID: 21324450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
    Kably Ambe A; Estévez González S; Carballo Mondragón E
    Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration.
    Guijarro Ponce JA; Núñez Calonge R
    Fertil Steril; 2011 Aug; 96(2):e137; author reply e138. PubMed ID: 21700281
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer].
    Xu SR; Li Y; Liu H; Li HY; Tang R; Gao Q; Sheng Y; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):420-3. PubMed ID: 21029591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
    Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of elevated estradiol levels on the hCG administration day on IVF pregnancy and birth outcomes in the long GnRH-agonist protocol: analysis of 3393 cycles.
    Wang M; Hao C; Bao H; Huang X; Liu Z; Zhang W; Li F
    Arch Gynecol Obstet; 2017 Feb; 295(2):407-414. PubMed ID: 27858152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles.
    Huang R; Fang C; Wang N; Li L; Yi Y; Liang X
    Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():177-82. PubMed ID: 24862918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
    Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
    Orvieto R; Rabinson J; Meltcer S; Gemer O; Anteby EY; Zohav E
    Fertil Steril; 2008 Mar; 89(3):736-7. PubMed ID: 17498708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate at which serum total beta-subunit human chorionic gonadotropin increases after embryo transfer is a predictor of the viability of pregnancy and an identifier of determinants of pregnancy.
    Stone BA; Vargyas JM; Ringler GE; March CM; Marrs RP
    Fertil Steril; 2006 Dec; 86(6):1626-33. PubMed ID: 17081527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of progesterone/estradiol ratio on day of hCG administration and pregnancy outcomes in high responders undergoing in vitro fertilization.
    Lee FK; Lai TH; Lin TK; Horng SG; Chen SC
    Fertil Steril; 2009 Oct; 92(4):1284-1289. PubMed ID: 18829018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone elevation on the day of human chorionic gonadotropin administration is not the only factor determining outcomes of in vitro fertilization.
    Tsai YR; Huang FJ; Lin PY; Kung FT; Lin YJ; Lin YC; Lan KC
    Fertil Steril; 2015 Jan; 103(1):106-11. PubMed ID: 25455869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
    Smeenk JM; Sweep FC; Zielhuis GA; Kremer JA; Thomas CM; Braat DD
    Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility.
    Matalliotakis IM; Cakmak H; Mahutte N; Fragouli Y; Arici A; Sakkas D
    Fertil Steril; 2007 Dec; 88(6):1568-72. PubMed ID: 17349642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.